-+ 0.00%
-+ 0.00%
-+ 0.00%

HUTCHMED launches Phase III China trial of HMPL-760 plus R-GemOx in relapsed/refractory DLBCL

路透·03/23/2026 00:00:18

登錄查看新聞詳情